Analytical Data
-
Gene name
CCL15
- Application
-
Alternative Names
CCL15；MIP5；NCC3；SCYA15；C-C motif chemokine 15
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16663
-
Expression Region
46-113aa
-
AA Sequence
SFHFAADCCT SYISQSIPCS LMKSYFETSS ECSKPGVIFL TKKGRQVCAK PSGPGVQDCM KKLKPYSI
-
Molecular Weight
7.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCL15, also known as Chemokine (C-C motif) ligand 15, is a member of the C-C chemokine family that plays an essential role in immune response and inflammation. It primarily acts as a chemotactic factor for monocytes and other immune cells, guiding them to sites of infection or tissue injury. Recent studies have highlighted its involvement in various pathological conditions, including cancer, autoimmune diseases, and chronic inflammatory disorders. Given its significant biological functions, CCL15 has gained attention as a potential therapeutic target and biomarker. The recombinant expression of CCL15 protein allows for detailed studies of its structure-function relationship, immunological properties, and interactions with its receptors. Such research is crucial for understanding the molecular mechanisms underlying its role in health and disease and for developing novel therapeutic strategies that could modulate immune responses. Additionally, recombinant CCL15 can be utilized in preclinical studies to investigate its potential as an immunotherapeutic agent. Overall, the exploration of CCL15 recombinant protein presents valuable insights into its utility in both basic research and clinical applications.
